DCGO EBITDA | DocGo Inc.

DocGo Inc. (DCGO) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	(m)	(m)	(m)	-20.74%	$320.83K*	-$9.24M*	(m)	$3.45M	(m)	$56.13K
2026-03-31	Reported	(m)	(m)	(m)	(m)	-21.26%	$430.31K	-$4.66M	(m)	$3.71M	(m)	$19.28K
2025-12-31	Reported	(m)	(m)	(m)	(m)	-134.29%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	(m)	(m)	(m)	(m)	-53.67%	$876.18K*	$1.66M*	(m)	$3.19M	(m)	-$13.51M
2025-06-30	Reported	(m)	(m)	(m)	(m)	-16.79%	$1.14M*	$34.04M*	(m)	$2.96M	(m)	-$4.63M
2025-03-31	Reported	(m)	(m)	(m)	(m)	-10.66%	$1.03M	$9.22M	(m)	$3.64M	(m)	-$3.72M
2024-12-31	Reported	(m)	(m)	(m)	(m)	-3.43%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	(m)	(m)	(m)	(m)	10.32%	$902.16K*	$31.15M*	(m)	$3.15M	(m)	$4.49M
2024-06-30	Reported	(m)	(m)	(m)	(m)	8.70%	$1.03M*	$36.89M*	(m)	$2.37M	(m)	$3.71M
2024-03-31	Reported	(m)	(m)	(m)	(m)	10.44%	$951.70K	-$10.64M	(m)	$2.39M	(m)	$5.12M
2023-12-31	Reported	(m)	(m)	(m)	(m)	11.75%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$10.33M*	$8.71M	$1.63M*	(m)	(m)	$801.15K*	-$45.88M*	(m)	$3.24M	(m)	$4.53M
2023-06-30	Reported	$3.17M*	$1.58M	$1.59M*	(m)	(m)	$1.58M*	$10.69M*	(m)	$2.57M	(m)	-$355.05K
2023-03-31	Reported	(m)	(m)	(m)	(m)	-4.80%	$1.98M	-$23.12M	(m)	$1.86M	(m)	-$2.13M
2022-12-31	Reported	(m)	(m)	(m)	(m)	7.40%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$5.35M*	$4.20M	$1.15M*	(m)	(m)	$1.05M*	$7.42M*	(m)	$1.37M	(m)	$401.92K
2022-06-30	Reported	(m)	$7.46M	(m)	(m)	(m)	$339.24K*	$11.92M*	(m)	$1.15M	(m)	$321.66K
2022-03-31	Reported	(m)	$10.09M	(m)	(m)	(m)	$602.42K	$18.26M	(m)	$1.14M	(m)	$440.18K
2021-09-30	Reported	(m)	$1.52M	(m)	(m)	(m)	$243.22K*	$8.00M*	(m)	$854.62K	(m)	$604.61K
2021-06-30	Reported	(m)	$258.76K	(m)	(m)	(m)	$1.82M*	$238.78K*	(m)	$664.88K	(m)	-$1.11K
2021-03-31	Reported	(m)	-$1.87M	(m)	(m)	(m)	$760.05K	-$1.38M	(m)	$569.35K	(m)	$10.03K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	(m)	(m)	(m)	-50.40%	$4.54M	$34.45M	(m)	$13.56M	(m)	$8.87M
2024-12-31	Reported	(m)	(m)	(m)	(m)	7.23%	$3.61M	$70.12M	(m)	$11.59M	(m)	$14.39M
2023-12-31	Reported	(m)	(m)	(m)	(m)	5.04%	$7.31M	-$64.49M	(m)	$10.86M	(m)	$6.24M
2022-12-31	Reported	(m)	(m)	(m)	(m)	7.35%	$3.20M	$28.87M	(m)	$5.38M	(m)	-$7.96M
2021-12-31	Reported	(m)	(m)	(m)	(m)	5.54%	$4.81M	-$1.95M	(m)	$3.32M	(m)	$615.70K
2020-12-31	Reported	(m)	-$14.76M	(m)	(m)	(m)	$4.36M	-$10.65M	(m)	$1.19M	(m)	$167.44K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
VSEE HEALTH, INC. (VSEE)	United States	$0.003B
Agape ATP Corp (ATPC)		$0.002B
Strata Critical Medical, Inc. (SRTA)	United States	$0.467B	11.33
InnovAge Holding Corp. (INNV)	United States	$1.206B	-635.60
Omada Health, Inc. (OMDA)	United States	$1.207B	309.08
U S PHYSICAL THERAPY INC /NV (USPH)	United States	$1.251B	32.48
Pennant Group, Inc. (PNTG)	United States	$1.386B	39.84
Privia Health Group, Inc. (PRVA)	United States	$2.477B	115.52
GeneDx Holdings Corp. (WGS)	United States	$2.638B	-19.23
LifeStance Health Group, Inc. (LFST)	United States	$4.510B	80.86